Imalux Corporation

About:

Imalux Corporation is a novel imaging technology, Optical Coherence Tomography (OCT).

Top Investors: BeyondTrust, Electrosonic, Reservoir Venture Partners, Early Stage Partners, Biomec

Description:

Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety of medical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care.

Total Funding Amount:

$14.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

1996-01-01

Contact Email:

info(AT)imalux.com

Founders:

Michael Burke

Number of Employees:

1-10

Last Funding Date:

2012-06-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai